Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anna Malmerfelt
Reboxetine Enhances the Olanzapine-Induced Antipsychotic-Like Effect, Cortical Dopamine Outflow and NMDA Receptor-Mediated Transmission
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
Related publications
Presynaptic Inhibition Preferentially Reduces the NMDA Receptor-Mediated Component of Transmission in Rat Midbrain Dopamine Neurons
British Journal of Pharmacology
Pharmacology
Effect of Zinc on NMDA Receptor-Mediated Channel Currents in Cortical Neurons
Journal of Neuroscience
Neuroscience
Social Isolation Induces Schizophrenia-Like Behavior Potentially Associated With HINT1, NMDA Receptor, and Dopamine Receptor 2
NeuroReport
Neuroscience
Olanzapine-Induced Respiratory Dyskinesia: A Case Report of a Rarely Recognized Antipsychotic Adverse Effect
Journal of Medical Science And clinical Research
Decreased Prefrontal Cortical Dopamine Transmission in Alcoholism
American Journal of Psychiatry
Psychiatry
Mental Health
TAAR1 Modulates Cortical Glutamate NMDA Receptor Function
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
Dopamine D1 Receptor-Mediated Enhancement of NMDA Receptor Trafficking Requires Rapid PKC-dependent Synaptic Insertion in the Prefrontal Neurons
Journal of Neurochemistry
Biochemistry
Molecular Neuroscience
Cellular
DPCPX, a Selective Adenosine A1 Receptor Antagonist, Enhances the Antidepressant-Like Effects of Imipramine, Escitalopram, and Reboxetine in Mice Behavioral Tests
Naunyn-Schmiedeberg's Archives of Pharmacology
Medicine
Pharmacology
NMDA and Dopamine Converge on the NMDA-Receptor to Induce ERK Activation and Synaptic Depression in Mature Hippocampus
PLoS ONE
Multidisciplinary
